|
 |
| home > ebr > winter 2005 > indian biotech – a fledgling industry takes flight |
|
|
 PUBLICATIONS |
Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time.
Sign up now!
Already registered? Please sign in.
Alternatively, please use our pay-per-view service. |
|
|
 |
Industry Events |
 |
CPhI India
1-3 December 2010, Mumbai, India
With the Indian market fast becoming a major global economy and with its pharmaceutical market expected to treble over the years to 2015, CPhI India 2009 is a unique chance to link up with the very best in this industry as they gather to discuss the key issues, trends and developments in one location. Generate new alliances, renew existing partnerships and benefit from the dynamic networking opportunities available to actively drive your business forward. Attend CPhI India 2009 – the perfect environment for growth.
More info >> |
|
 |
News and Press Releases |
 |
Glycotope GMBH
Berlin, Germany – August 4, 2010
Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX (GT-MAB 5.2-GEX) for the treatment of various solid cancers.
More info >> |
|
|
